Skip to main content

Cystinuria

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Himalaya Therapeutics
Himalaya TherapeuticsChina - Hong Kong
1 program
1
CystonePhase 1/21 trial
Active Trials
NCT00381849Completed20Est. Jun 2010
Otsuka
OtsukaJapan - Tokushima
1 program
TolvaptanN/A1 trial
Active Trials
NCT02538016Completed4Est. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Himalaya TherapeuticsCystone
OtsukaTolvaptan

Clinical Trials (2)

Total enrollment: 24 patients across 2 trials

Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones

Start: Apr 2006Est. completion: Jun 201020 patients
Phase 1/2Completed

TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

Start: Oct 2016Est. completion: Dec 20184 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.